This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Societe Des Produits Nestle S.a.. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: Robin Willows: Innovator in AMPK Activation Compounds
Introduction
Robin Willows is a notable inventor based in Echandens, Switzerland. He has made significant contributions to the field of cardiometabolic health through his innovative research and development of compounds that activate AMPK. His work is particularly relevant in addressing conditions such as obesity, type 2 diabetes, and cardiovascular diseases.
Latest Patents
Willows holds a patent for "Direct AMPK activator compounds." This invention relates to a compound with a general formula for use in the activation of AMPK. The patent includes a composition comprising said compound, which is essential for improving various health conditions. The compounds he developed are 9,10 dihydrophenanthrenes, specifically including: (i) Lusianthridin, (ii) 7-Methoxy-9,10-dihydrophenanthrene-2,3,5-triol, (iii) 9,10-dihydrophenanthrene-2,5-diol, (iv) 9,10-Dihydrophenanthrene-2,4,7-triol, and (v) 9,10-Dihydro-7-methoxy-3,5-phenanthrenediol. The activation of AMPK is crucial for improving conditions related to cardiometabolic health, obesity, type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease, and cancer. Willows has 1 patent to his name.
Career Highlights
Robin Willows is currently employed at Société des Produits Nestlé S.A., where he continues to innovate and contribute to the field of health and nutrition. His work at Nestlé allows him to collaborate with other experts in the industry and further develop his research.
Collaborations
Willows has worked alongside notable colleagues such as Denis Marcel Barron and Yann Ratinaud. Their combined expertise enhances the research and development efforts within their organization.
Conclusion
Robin Willows is a distinguished inventor whose work in AMPK activation compounds has the potential to significantly impact health outcomes related to various diseases. His contributions to the field are invaluable, and his ongoing research promises to lead to further advancements in cardiometabolic health.